Global Molecular Diagnostics Devices And Equipment Market
Medical Equipment

Molecular Diagnostics Devices And Equipment Market Forecast 2026–2035: Data Trends and Industry Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Molecular Diagnostics Devices And Equipment Market between 2026 and 2030?

The molecular diagnostics devices and equipment market size has seen rapid expansion in recent years. It is projected to increase from $27.23 billion in 2025 to $30.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.4%. The historical growth in this market can be linked to factors such as an increase in infectious disease testing, the broadening of genetic screening programs, a rise in the application of molecular diagnostics in oncology, enhancements in sequencing accuracy, and heightened clinical awareness of molecular testing.

The molecular diagnostics devices and equipment market size is projected to experience substantial growth in the coming years, with expectations to reach $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. This anticipated expansion during the forecast period is largely due to factors such as the increasing demand for personalized medicine, greater investments in genomic diagnostics, the broadening of decentralized molecular testing, the rising adoption of automated sample processing, and a heightened emphasis on early-stage disease detection. Significant trends during this period involve the increasing uptake of PCR-based testing platforms, the rising utilization of next-generation sequencing technologies, the expanding integration of diagnostic software and bioinformatics, the growth of companion diagnostics applications, and an enhanced focus on early and personalized diagnosis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

Which Drivers Are Expected To Impact The Molecular Diagnostics Devices And Equipment Market During The Forecast Period?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the molecular diagnostic devices and equipment market in the future. These diseases are defined as ailments resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of spreading between individuals or from animals to humans. The growing prevalence of infectious diseases stems from various factors, including antimicrobial resistance, increased globalization and travel, urbanization, socioeconomic inequalities, and a demographic shift towards an older population. Crucially, molecular diagnostic devices and equipment serve as vital instruments for identifying and managing infectious diseases. As an illustration, data from the Centers for Disease Control and Prevention, a US-based government agency, shows that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Furthermore, the incidence rate advanced from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Consequently, the escalating incidence of infectious diseases is propelling the expansion of the molecular diagnostic devices and equipment market.

How Is The Molecular Diagnostics Devices And Equipment Market Divided Into Segments?

The molecular diagnostics devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

How Are New Market Trends Shaping The Landscape Of The Molecular Diagnostics Devices And Equipment Market?

Leading companies in the molecular diagnostics devices and equipment market are actively developing innovative products, such as high-throughput sample-to-result instruments for molecular diagnostics. This high-throughput system will be built upon ELITech’s proven extraction and assay technology, and it will utilize the same reagents as InGenius and BeGenius. For example, in April 2023, ELITechGroup, a France-based company focused on integrated in-vitro diagnostics, launched a high-throughput sample-to-result instrument specifically for molecular diagnostics. This instrument allows for continuous loading of samples and reagents, combined with true random-access capabilities, enabling users to run diverse PCR reagents, protocols, and sample matrices in parallel with high versatility.

Which Leading Companies Dominate The Molecular Diagnostics Devices And Equipment Market Share?

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Molecular Diagnostics Devices And Equipment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company

Dental Diagnostic Imaging Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Point Of Care Molecular Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company